Drug prevents bone loss in prostate cancer: Amgen

Category: Science

Publish Date: 07-14-2008 09:41 AM -0700

CHICAGO (Reuters) - Amgen Inc on Monday said that a trial of its experimental drug denosumab showed that it can prevent osteoporosis in men being treated with prostate cancer drugs that can cause bone loss.

Continue to Original Story >